Found 9 results

Name Type of Offering Accepted Date
First Eagle Value in Biotechnology Fund (QP), LP
D/A 2011-03-10
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001481559
Filed Document 0000919574-11-002088
Exclusions or Exemptions N/A
Accepted Date 2011-03-10
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Pooled Investment Fund
First Eagle Value in Biotechnology Fund (QP), LP
D/A 2015-03-12
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001481559
Filed Document 0000919574-15-002837
Exclusions or Exemptions 506b
Accepted Date 2015-03-12
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Pooled Investment Fund
First Eagle Value in Biotechnology Fund (QP), LP
D/A 2012-03-12
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001481559
Filed Document 0000919574-12-002166
Exclusions or Exemptions N/A
Accepted Date 2012-03-12
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Pooled Investment Fund
First Eagle Value in Biotechnology Fund (QP), LP
D/A 2016-03-14
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001481559
Filed Document 0000919574-16-011860
Exclusions or Exemptions 506b
Accepted Date 2016-03-14
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
First Eagle Value in Biotechnology Fund (QP), LP
D 2010-03-10
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001481559
Filed Document 0000919574-10-002234
Exclusions or Exemptions N/A
Accepted Date 2010-03-10
Type of Offering D
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Pooled Investment Fund
First Eagle Value in Biotechnology Fund (QP), LP
D/A 2013-03-12
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001481559
Filed Document 0000919574-13-002271
Exclusions or Exemptions N/A
Accepted Date 2013-03-12
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Pooled Investment Fund
First Eagle Value in Biotechnology Fund (QP), LP
D/A 2014-03-12
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001481559
Filed Document 0000919574-14-002223
Exclusions or Exemptions 506b
Accepted Date 2014-03-12
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Pooled Investment Fund
First Eagle Value in Biotechnology Fund (QP), LP
D/A 2017-03-13 15:56:53
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001481559
Filed Document 0000919574-17-002741
Exclusions or Exemptions 506b
Accepted Date 2017-03-13 15:56:53
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
First Eagle Value in Biotechnology Fund (QP), LP
D/A 2018-03-13 14:39:16
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001481559
Filed Document 0000919574-18-002434
Exclusions or Exemptions 506b
Accepted Date 2018-03-13 14:39:16
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity